1,711
Views
19
CrossRef citations to date
0
Altmetric
Brief Report

Attenuation of Pseudomonas aeruginosa infection by INP0341, a salicylidene acylhydrazide, in a murine model of keratitis

, ORCID Icon &
Pages 795-804 | Received 24 Oct 2019, Accepted 18 May 2020, Published online: 07 Jun 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xiubin Ma, Qing Liu, Fangying Song & Yusen Huang. (2022) Differentially Expressed Genes of Pseudomonas aeruginosa Isolates from Eyes with Keratitis and Healthy Conjunctival Sacs. Infection and Drug Resistance 15, pages 4495-4506.
Read now

Articles from other publishers (18)

Cesar de la Fuente-Nunez, Angela Cesaro & Robert E.W. Hancock. (2023) Antibiotic failure: Beyond antimicrobial resistance. Drug Resistance Updates 71, pages 101012.
Crossref
Colya N. Englisch, Noran Abdel Wadood, Linda Pätzold, Andrew Gallagher, Gabriela Krasteva-Christ, Sören L. Becker & Markus Bischoff. (2023) Establishing an experimental Pseudomonas aeruginosa keratitis model in mice – Challenges and solutions. Annals of Anatomy - Anatomischer Anzeiger 249, pages 152099.
Crossref
Praveen Kumar Jadi, Alpana Dave, Rahaf Issa, Khatija Tabbasum, Katarzyna Okurowska, Apurwa Samarth, Lucy Urwin, Luke R. Green, Lynda J. Partridge, Sheila MacNeil, Prashant Garg, Peter N. Monk & Sanhita Roy. (2023) Tetraspanin CD9-derived peptides inhibit Pseudomonas aeruginosa corneal infection and aid in wound healing of corneal epithelial cells. The Ocular Surface.
Crossref
Lawson Ung & James Chodosh. (2023) Urgent unmet needs in the care of bacterial keratitis: An evidence-based synthesis. The Ocular Surface 28, pages 378-400.
Crossref
Nadja Blasey, Daria Rehrmann, Anna Katharina Riebisch & Sabrina Mühlen. (2023) Targeting bacterial pathogenesis by inhibiting virulence-associated Type III and Type IV secretion systems. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Stephen J. Wood, Timothy M. Kuzel & Sasha H. Shafikhani. (2023) Pseudomonas aeruginosa: Infections, Animal Modeling, and Therapeutics. Cells 12:1, pages 199.
Crossref
Stephen J. Wood, Josef W. Goldufsky, Michelle Y. Seu, Amir H. Dorafshar & Sasha H. Shafikhani. (2023) Pseudomonas aeruginosa Cytotoxins: Mechanisms of Cytotoxicity and Impact on Inflammatory Responses. Cells 12:1, pages 195.
Crossref
Priyasha Mishra, Sanjay Ch, Seok Jong Hong, Swati Biswas & Sanhita Roy. (2022) Antimicrobial peptide S100A12 (calgranulin C) inhibits growth, biofilm formation, pyoverdine secretion and suppresses type VI secretion system in Pseudomonas aeruginosa. Microbial Pathogenesis 169, pages 105654.
Crossref
Riccardo Zambelloni, Katherine S.H. Beckham, Hong-Jin Wu, Mikael Elofsson, Rudi Marquez, Mads Gabrielsen & Andrew J. Roe. (2022) Crystal structures of WrbA, a spurious target of the salicylidene acylhydrazide inhibitors of type III secretion in Gram-negative pathogens, and verification of improved specificity of next-generation compounds. Microbiology 168:7.
Crossref
Sk Abdul Mohid, Prerana Sharma, Amani Alghalayini, Tripti Saini, Debarun Datta, Mark D.P. Willcox, Haydar Ali, Sreyan Raha, Achintya Singha, DongKuk Lee, Nirakar Sahoo, Charles G. Cranfield, Sanhita Roy & Anirban Bhunia. (2022) A rationally designed synthetic antimicrobial peptide against Pseudomonas-associated corneal keratitis: Structure-function correlation. Biophysical Chemistry 286, pages 106802.
Crossref
Rohan Bir Singh, Sujata Das, James Chodosh, Namrata Sharma, Michael E. Zegans, Regis P. Kowalski & Vishal Jhanji. (2022) Paradox of complex diversity: Challenges in the diagnosis and management of bacterial keratitis. Progress in Retinal and Eye Research 88, pages 101028.
Crossref
Joanna B. Goldberg, Cristian V. Crisan & Justin M. Luu. 2022. Pseudomonas aeruginosa. Pseudomonas aeruginosa 257 280 .
Miguel A. Matilla, Félix Velando, Elizabet Monteagudo-Cascales & Tino Krell. 2022. Pseudomonas aeruginosa. Pseudomonas aeruginosa 185 221 .
Sanjay Ch, Priyasha Mishra, Himanshu Bhatt, Balaram Ghosh, Sanhita Roy & Swati Biswas. (2021) Hydroxypropyl methacrylamide-based copolymeric nanoparticles loaded with moxifloxacin as a mucoadhesive, cornea-penetrating nanomedicine eye drop with enhanced therapeutic benefits in bacterial keratitis. Colloids and Surfaces B: Biointerfaces 208, pages 112113.
Crossref
Lakshmi Sruthi Mallela, Prerana Sharma, Tata Santosh RamaBhadra Rao & Sanhita Roy. (2021) Recombinant IL ‐22 promotes protection in a murine model of Aspergillus flavus keratitis and mediates host immune responses in human corneal epithelial cells . Cellular Microbiology 23:9.
Crossref
Praveen Kumar Jadi, Prerana Sharma, Bharathi Bhogapurapu & Sanhita Roy. (2021) Alternative Therapeutic Interventions: Antimicrobial Peptides and Small Molecules to Treat Microbial Keratitis. Frontiers in Chemistry 9.
Crossref
Lawson Ung & James Chodosh. (2021) Foundational concepts in the biology of bacterial keratitis. Experimental Eye Research 209, pages 108647.
Crossref
Julia A. Hotinger, Heather A. Pendergrass & Aaron E. May. (2021) Molecular Targets and Strategies for Inhibition of the Bacterial Type III Secretion System (T3SS); Inhibitors Directly Binding to T3SS Components. Biomolecules 11:2, pages 316.
Crossref